SOPHIA GENETICS SA
SOPH·H82027105·US·Common Stock·Healthcare - Health Information Services-13D/G
SOPH (SOPHIA GENETICS SA) is held by 41 institutional investors as of Q2 2026. Largest holders: GENERATION INVESTMENT MANAGEMENT LLP ($39.2M), AKRE CAPITAL MANAGEMENT LLC ($21.5M), ROYCE & ASSOCIATES LP ($19.5M). Net institutional sentiment: Bullish.
41
Holders
(3 Elite)
$138.7M
Total Value
71% (38)
Consensus
27 buying - 11 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Aug 28, 2026 · Insiders Aug 26, 2026 · Activists Feb 11, 2026 · Congress none
InsiderMPMenu PhilippeSell $43KAug 25, 2026
InsiderHLHIBBS KATHY LSell $54KAug 25, 2026
InsiderVAVerma AbhimanyuSell $44KAug 24, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 45
1 / 3
Continue exploring
Other Healthcare stocks held by institutions
403 holders · $856.6B
403 holders · $286.8B
388 holders · $148B
385 holders · $405.5B
384 holders · $95B
381 holders · $105.8B
378 holders · $226B
375 holders · $51.2B
373 holders · $296.3B
371 holders · $110.7B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer